RxDoctor Payments Data

Patricia Okeke, NP

Women's Health · Newnan, GANPI 1841906278

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $966, more than ten times the $15 reported in 2023.

$1,447in general payments, 2019–2025

Across 69 payments — averaging $20.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$200
  • Sanofi-aventis U.S. LLC$174
  • Bayer$149
  • Boehringer Ingelheim$113
  • Pfizer$99
  • Johnson & Johnson$97
  • plus $617 from 17 others

What the payments were for

  • Food & beverage$1,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,447 in reported general payments places this provider in the 80th percentile of 247 women's health providers in Georgia.

See all women's health providers in Georgia

Medicare billing

Part B allowed, 2024
$23,676
Medicare patients
219
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin26$462
Atorvastatin Calcium59$459
Diclofenac Sodium21$343
FenofibrateFenofibrate Nanocrystallized12$342
Amlodipine Besylate64$294
Omeprazole41$276
Levothyroxine Sodium34$195
Rosuvastatin Calcium20$193
Pravastatin Sodium18$165
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide11$153
ClopidogrelClopidogrel Bisulfate11$146
Pantoprazole Sodium13$125
Fluticasone Propionate13$117
Simvastatin16$115
Metformin Hcl28$109

Paid to pharmacies, not to this prescriber.

Other women's health in Newnan

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →